Skip to contentS
Sensus Healthcare, Inc.
S
SRTSSensus Healthcare, Inc. Q2 2025 · 10-Q
Revenue$7.32M$7.32M−20.8% vs Q2 2024 Net Income-$1.04M-$1.04MN/M vs Q2 2024 EPS Diluted-$0.06-$0.06N/M vs Q2 2024 Gross Profit$2,903,000−46.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sensus Healthcare, Inc. · CIK 1494891 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,117,000−26.3% Free Cash Flowderived$3,090,000−26.9% Margins · derivedGross margin39.7%−19.0 pt vs Q2 2024
Operating margin-26.6%−48.0 pt vs Q2 2024
Net margin-14.2%−31.6 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 12, 2025 · 43 d after period end